التفاصيل البيبلوغرافية
| العنوان: |
A randomised phase II trial of a trivalent ganglioside vaccine targeting GM2, GD2 and GD3 combined with immunological adjuvant OPT-821 versus OPT-821 alone in metastatic sarcoma patients rendered disease-free by surgery |
| المؤلفون: |
Rosenbaum, Evan, Chugh, Rashmi, Ryan, Christopher W., Agulnik, Mark, Milhem, Mohammed M., George, Suzanne, Jones, Robin L., Chmielowski, Bartosz, Van Tine, Brian A., Tawbi, Hussein, Elias, Anthony D., Read, William L., Budd, G. Thomas, Qin, Li-Xuan, Rodler, Eve T., Hirman, Joe, Weiden, Paul, Bennett, Cathryn M., Livingston, Philip O., Ragupathi, Govind, Hansen, David, D'Angelo, Sandra P., Tap, William D., Schwartz, Gary K., Maki, Robert G., Carvajal, Richard D. |
| المساهمون: |
National Cancer Institute |
| المصدر: |
European Journal of Cancer ; volume 176, page 155-163 ; ISSN 0959-8049 |
| بيانات النشر: |
Elsevier BV |
| سنة النشر: |
2022 |
| المجموعة: |
ScienceDirect (Elsevier - Open Access Articles via Crossref) |
| مصطلحات موضوعية: |
Cancer Research, Oncology |
| نوع الوثيقة: |
article in journal/newspaper |
| اللغة: |
English |
| DOI: |
10.1016/j.ejca.2022.09.003 |
| الإتاحة: |
https://doi.org/10.1016/j.ejca.2022.09.003Test
https://api.elsevier.com/content/article/PII:S0959804922005287?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S0959804922005287?httpAccept=text/plainTest |
| حقوق: |
https://www.elsevier.com/tdm/userlicense/1.0Test/ ; http://www.elsevier.com/open-access/userlicense/1.0Test/ ; https://doi.org/10.15223/policy-017Test ; https://doi.org/10.15223/policy-037Test ; https://doi.org/10.15223/policy-012Test ; https://doi.org/10.15223/policy-029Test ; https://doi.org/10.15223/policy-004Test |
| رقم الانضمام: |
edsbas.47F4358B |
| قاعدة البيانات: |
BASE |
